Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou1f1
|
ENSMUSG00000004842.12 | POU domain, class 1, transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr16_65514377_65514528 | Pou1f1 | 6059 | 0.207012 | 0.19 | 1.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_112695608_112695943 | 92.33 |
Gm18883 |
predicted gene, 18883 |
3904 |
0.16 |
chr16_85092305_85093056 | 17.70 |
Gm49227 |
predicted gene, 49227 |
12569 |
0.2 |
chr10_16052455_16052829 | 17.65 |
C330004P14Rik |
RIKEN cDNA C330004P14 gene |
260865 |
0.02 |
chr9_41273094_41273386 | 15.90 |
Gm48710 |
predicted gene, 48710 |
44358 |
0.11 |
chr2_136713076_136713349 | 15.89 |
Snap25 |
synaptosomal-associated protein 25 |
241 |
0.93 |
chr8_89324466_89324831 | 14.50 |
Gm5356 |
predicted pseudogene 5356 |
137088 |
0.05 |
chr3_19406344_19406802 | 14.39 |
Pde7a |
phosphodiesterase 7A |
95251 |
0.07 |
chr12_27248179_27248503 | 14.36 |
Gm47860 |
predicted gene, 47860 |
15165 |
0.27 |
chr13_85066695_85066901 | 14.25 |
Gm47745 |
predicted gene, 47745 |
27537 |
0.17 |
chr7_60450080_60450452 | 13.71 |
Gm30196 |
predicted gene, 30196 |
157062 |
0.03 |
chr10_43023952_43024111 | 13.52 |
Gm47815 |
predicted gene, 47815 |
10962 |
0.22 |
chr7_6435396_6435733 | 13.16 |
Olfr1344 |
olfactory receptor 1344 |
3124 |
0.1 |
chr14_99749385_99749857 | 12.85 |
Gm22970 |
predicted gene, 22970 |
24187 |
0.19 |
chr8_55026049_55026477 | 12.80 |
Gm45264 |
predicted gene 45264 |
2138 |
0.23 |
chr14_38825108_38825292 | 12.67 |
Nrg3os |
neuregulin 3, opposite strand |
73102 |
0.12 |
chr3_107114477_107114841 | 12.66 |
Kcna2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
11977 |
0.14 |
chr18_25377822_25377990 | 12.57 |
Gm16558 |
predicted gene 16558 |
13895 |
0.27 |
chr7_31127074_31128340 | 12.46 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr10_29217677_29217828 | 12.39 |
9330159F19Rik |
RIKEN cDNA 9330159F19 gene |
6047 |
0.18 |
chr17_79550311_79550635 | 12.31 |
Rmdn2 |
regulator of microtubule dynamics 2 |
61390 |
0.13 |
chr16_63806861_63807216 | 12.27 |
Epha3 |
Eph receptor A3 |
56375 |
0.15 |
chr12_120015533_120015684 | 12.26 |
Gm27236 |
predicted gene 27236 |
15081 |
0.24 |
chr4_110050502_110051534 | 12.17 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chr12_26635257_26635560 | 12.17 |
1700020D12Rik |
RIKEN cDNA 1700020D12 gene |
33099 |
0.18 |
chr10_58227289_58228680 | 12.12 |
Gm10807 |
predicted gene 10807 |
667 |
0.56 |
chr13_29415973_29416331 | 12.09 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
58455 |
0.16 |
chr12_112542537_112542889 | 12.07 |
Tmem179 |
transmembrane protein 179 |
25966 |
0.13 |
chr2_54265163_54265368 | 12.06 |
Gm14035 |
predicted gene 14035 |
18850 |
0.21 |
chr12_29789338_29789752 | 11.98 |
Myt1l |
myelin transcription factor 1-like |
50665 |
0.17 |
chr4_54371542_54371700 | 11.91 |
Gm12469 |
predicted gene 12469 |
135745 |
0.05 |
chr3_101343856_101344007 | 11.83 |
Gm43467 |
predicted gene 43467 |
33085 |
0.11 |
chr11_42420596_42421002 | 11.75 |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
480 |
0.89 |
chr3_10685679_10685948 | 11.65 |
Gm37831 |
predicted gene, 37831 |
39497 |
0.17 |
chr6_55792592_55792989 | 11.61 |
Itprid1 |
ITPR interacting domain containing 1 |
44105 |
0.18 |
chr1_96346717_96347057 | 11.55 |
Gm37076 |
predicted gene, 37076 |
33645 |
0.18 |
chr1_51650752_51650944 | 11.45 |
Gm28055 |
predicted gene 28055 |
47052 |
0.14 |
chr1_20905491_20905707 | 11.44 |
Gm24171 |
predicted gene, 24171 |
9941 |
0.12 |
chr14_75455687_75456060 | 11.41 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
109 |
0.97 |
chr1_42691969_42692512 | 11.39 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
853 |
0.48 |
chr13_23949986_23950148 | 11.39 |
Scgn |
secretagogin, EF-hand calcium binding protein |
5512 |
0.1 |
chr15_25754647_25755340 | 11.27 |
Myo10 |
myosin X |
2014 |
0.38 |
chr6_39871251_39871962 | 11.23 |
Tmem178b |
transmembrane protein 178B |
145 |
0.75 |
chr1_92224585_92224856 | 11.08 |
Hdac4 |
histone deacetylase 4 |
29021 |
0.2 |
chr16_76866459_76866678 | 11.08 |
1700041M19Rik |
RIKEN cDNA 1700041M19 gene |
22713 |
0.18 |
chr14_12377401_12377552 | 11.07 |
Cadps |
Ca2+-dependent secretion activator |
197 |
0.91 |
chr13_84571062_84571255 | 11.03 |
Gm26913 |
predicted gene, 26913 |
119783 |
0.06 |
chr3_68202202_68202415 | 11.00 |
Gm10292 |
predicted gene 10292 |
130888 |
0.05 |
chr1_194746751_194747168 | 10.94 |
2900035J10Rik |
RIKEN cDNA 2900035J10 gene |
14252 |
0.16 |
chr9_102235369_102235971 | 10.82 |
Gm37260 |
predicted gene, 37260 |
38066 |
0.14 |
chr1_9127833_9128130 | 10.73 |
Gm37629 |
predicted gene, 37629 |
64135 |
0.12 |
chr2_53105833_53106109 | 10.66 |
Prpf40a |
pre-mRNA processing factor 40A |
39338 |
0.2 |
chr13_8829855_8830018 | 10.65 |
Gm48375 |
predicted gene, 48375 |
4436 |
0.14 |
chr3_69709128_69709981 | 10.63 |
Rpl32-ps |
ribosomal protein L32, pseudogene |
7839 |
0.17 |
chr14_12393556_12393971 | 10.43 |
Gm48267 |
predicted gene, 48267 |
8467 |
0.14 |
chr13_83739197_83739995 | 10.41 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
733 |
0.33 |
chr1_67366568_67366878 | 10.36 |
Gm26342 |
predicted gene, 26342 |
109499 |
0.06 |
chr6_7367364_7367515 | 10.32 |
Gm44046 |
predicted gene, 44046 |
8528 |
0.26 |
chr3_98211633_98211906 | 10.27 |
Reg4 |
regenerating islet-derived family, member 4 |
10387 |
0.15 |
chr17_65961618_65962124 | 10.19 |
Ankrd12 |
ankyrin repeat domain 12 |
10521 |
0.14 |
chr9_89850032_89850330 | 10.11 |
4930524O08Rik |
RIKEN cDNA 4930524O08 gene |
23199 |
0.15 |
chr1_42703489_42704501 | 10.05 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4057 |
0.16 |
chr5_16134186_16134593 | 9.96 |
Gm43490 |
predicted gene 43490 |
27260 |
0.22 |
chr17_15977766_15977946 | 9.93 |
Eif3s6-ps3 |
eukaryotic translation initiation factor 3, subunit 6, pseudogene 3 |
132576 |
0.04 |
chr3_10685256_10685662 | 9.93 |
Gm37831 |
predicted gene, 37831 |
39143 |
0.17 |
chr9_37625246_37625717 | 9.88 |
Siae |
sialic acid acetylesterase |
3827 |
0.14 |
chr8_54954036_54954355 | 9.88 |
Gpm6a |
glycoprotein m6a |
648 |
0.67 |
chr13_110115014_110115173 | 9.85 |
Rab3c |
RAB3C, member RAS oncogene family |
165057 |
0.04 |
chr12_51241196_51241415 | 9.85 |
Rps11-ps4 |
ribosomal protein S11, pseudogene 4 |
56182 |
0.14 |
chr2_53437450_53438022 | 9.82 |
Gm13501 |
predicted gene 13501 |
39249 |
0.2 |
chr7_132767494_132767645 | 9.78 |
Fam53b |
family with sequence similarity 53, member B |
9347 |
0.2 |
chr13_83740093_83740300 | 9.77 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1333 |
0.24 |
chr17_48999548_48999943 | 9.73 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
67366 |
0.11 |
chr1_56345109_56345287 | 9.65 |
Gm28900 |
predicted gene 28900 |
106209 |
0.08 |
chr16_7159116_7159477 | 9.63 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
34451 |
0.25 |
chr7_82872320_82872576 | 9.52 |
Mex3b |
mex3 RNA binding family member B |
5115 |
0.17 |
chrX_158925108_158925309 | 9.48 |
Gm5764 |
predicted gene 5764 |
91773 |
0.09 |
chr4_72384628_72385513 | 9.46 |
Gm11235 |
predicted gene 11235 |
157596 |
0.04 |
chr10_112572699_112572878 | 9.46 |
Kcnc2 |
potassium voltage gated channel, Shaw-related subfamily, member 2 |
116445 |
0.06 |
chr11_14350814_14351136 | 9.46 |
Gm12006 |
predicted gene 12006 |
136638 |
0.05 |
chr14_77377991_77378204 | 9.45 |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
2482 |
0.31 |
chr12_15811718_15812067 | 9.44 |
Trib2 |
tribbles pseudokinase 2 |
4893 |
0.17 |
chr11_112501711_112502406 | 9.38 |
BC006965 |
cDNA sequence BC006965 |
167340 |
0.04 |
chr8_28744035_28744223 | 9.38 |
Gm26795 |
predicted gene, 26795 |
150597 |
0.04 |
chr14_15785133_15785550 | 9.36 |
Gm31804 |
predicted gene, 31804 |
11652 |
0.26 |
chr1_42693315_42693672 | 9.35 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
340 |
0.76 |
chr5_32713265_32714499 | 9.32 |
Gm43852 |
predicted gene 43852 |
106 |
0.94 |
chr1_132200708_132201234 | 9.29 |
Lemd1 |
LEM domain containing 1 |
8 |
0.96 |
chr8_36924370_36924521 | 9.29 |
Dlc1 |
deleted in liver cancer 1 |
27912 |
0.19 |
chr16_74582674_74582854 | 9.28 |
Gm49671 |
predicted gene, 49671 |
23498 |
0.21 |
chr16_44530838_44531222 | 9.27 |
Mir3081 |
microRNA 3081 |
27099 |
0.17 |
chr6_114143677_114143828 | 9.23 |
Slc6a11 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 11 |
12333 |
0.19 |
chr9_41697271_41698297 | 9.21 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr4_56088829_56089012 | 9.17 |
Gm12520 |
predicted gene 12520 |
74020 |
0.11 |
chr11_41532495_41533004 | 9.17 |
Hspd1-ps3 |
heat shock protein 1 (chaperonin), pseudogene 3 |
34012 |
0.2 |
chr13_20472950_20473157 | 9.17 |
Elmo1 |
engulfment and cell motility 1 |
327 |
0.58 |
chr6_142386279_142386720 | 9.17 |
Recql |
RecQ protein-like |
475 |
0.56 |
chr6_15397521_15397861 | 9.12 |
Gm25470 |
predicted gene, 25470 |
7290 |
0.26 |
chr9_86287275_86287455 | 9.11 |
Gm16202 |
predicted gene 16202 |
29319 |
0.22 |
chr4_32432624_32432775 | 9.10 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
15264 |
0.25 |
chr10_95619676_95619912 | 9.10 |
Gm33336 |
predicted gene, 33336 |
12445 |
0.13 |
chr6_10969635_10970167 | 9.06 |
AA545190 |
EST AA545190 |
4477 |
0.3 |
chr5_103160967_103161542 | 9.03 |
Mapk10 |
mitogen-activated protein kinase 10 |
44675 |
0.17 |
chr2_11044819_11045093 | 9.01 |
Gm13264 |
predicted gene 13264 |
8083 |
0.13 |
chr11_80623114_80623380 | 9.00 |
C030013C21Rik |
RIKEN cDNA C030013C21 gene |
114141 |
0.05 |
chr5_84848501_84849167 | 8.98 |
Gm21006 |
predicted gene, 21006 |
18011 |
0.3 |
chr2_96475744_96476057 | 8.98 |
Lrrc4c |
leucine rich repeat containing 4C |
157684 |
0.04 |
chr18_72725467_72725618 | 8.95 |
Gm31819 |
predicted gene, 31819 |
475 |
0.9 |
chr7_87110681_87110885 | 8.94 |
Gm44925 |
predicted gene 44925 |
8084 |
0.27 |
chr11_32158171_32158538 | 8.94 |
Gm12109 |
predicted gene 12109 |
26651 |
0.12 |
chr2_115460480_115461045 | 8.91 |
3110099E03Rik |
RIKEN cDNA 3110099E03 gene |
51439 |
0.15 |
chr13_51425700_51425859 | 8.90 |
Gm32834 |
predicted gene, 32834 |
7093 |
0.21 |
chr5_148152376_148152527 | 8.88 |
Gm10167 |
predicted pseudogene 10167 |
31926 |
0.17 |
chr18_25678184_25678915 | 8.88 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
35221 |
0.19 |
chr3_34444262_34444454 | 8.87 |
Gm20515 |
predicted gene 20515 |
9261 |
0.18 |
chr6_18446901_18447365 | 8.86 |
Gm26233 |
predicted gene, 26233 |
2207 |
0.27 |
chr8_30648481_30648881 | 8.85 |
4933433F19Rik |
RIKEN cDNA 4933433F19 gene |
80288 |
0.11 |
chr9_20703833_20704274 | 8.84 |
Olfm2 |
olfactomedin 2 |
22884 |
0.12 |
chr3_5755164_5755385 | 8.75 |
Gm8797 |
predicted pseudogene 8797 |
4468 |
0.32 |
chr13_77864958_77865113 | 8.67 |
Fam172a |
family with sequence similarity 172, member A |
156251 |
0.04 |
chr5_44538067_44538460 | 8.67 |
Ldb2 |
LIM domain binding 2 |
3166 |
0.18 |
chr13_72028642_72028801 | 8.65 |
Irx1 |
Iroquois homeobox 1 |
64998 |
0.13 |
chr5_85240015_85240217 | 8.62 |
Gm21006 |
predicted gene, 21006 |
373271 |
0.01 |
chr2_91330284_91330767 | 8.61 |
Gm13787 |
predicted gene 13787 |
13664 |
0.15 |
chr12_48284505_48284715 | 8.61 |
Gm48587 |
predicted gene, 48587 |
210609 |
0.02 |
chr13_83727309_83727854 | 8.60 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
525 |
0.66 |
chr14_62455363_62455547 | 8.57 |
Gucy1b2 |
guanylate cyclase 1, soluble, beta 2 |
662 |
0.68 |
chr1_33495240_33495424 | 8.53 |
Gm29228 |
predicted gene 29228 |
13231 |
0.21 |
chr1_166280896_166281272 | 8.52 |
Ildr2 |
immunoglobulin-like domain containing receptor 2 |
26891 |
0.14 |
chr15_25761802_25762209 | 8.51 |
Myo10 |
myosin X |
3220 |
0.3 |
chr12_44401957_44402486 | 8.48 |
Gm48182 |
predicted gene, 48182 |
7569 |
0.2 |
chr3_21672509_21672900 | 8.48 |
Gm17935 |
predicted gene, 17935 |
24317 |
0.19 |
chrX_99482045_99482291 | 8.47 |
Pja1 |
praja ring finger ubiquitin ligase 1 |
10895 |
0.2 |
chrX_129098239_129098390 | 8.45 |
4930558G05Rik |
RIKEN cDNA 4930558G05 gene |
34017 |
0.22 |
chr14_47890672_47890828 | 8.42 |
4930447J18Rik |
RIKEN cDNA 4930447J18 gene |
8101 |
0.19 |
chr2_106074528_106074752 | 8.41 |
Gm29053 |
predicted gene 29053 |
34144 |
0.14 |
chr3_20986381_20986745 | 8.41 |
Gm7488 |
predicted gene 7488 |
63002 |
0.13 |
chr15_92743865_92744028 | 8.40 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
303 |
0.93 |
chr12_6815927_6816078 | 8.39 |
Gm48619 |
predicted gene, 48619 |
116249 |
0.07 |
chr3_17797861_17798083 | 8.39 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
2228 |
0.25 |
chr7_61939801_61940302 | 8.34 |
Mir344-2 |
microRNA 344-2 |
55 |
0.95 |
chr13_84346636_84346793 | 8.34 |
Gm26927 |
predicted gene, 26927 |
6601 |
0.24 |
chr10_95040613_95040821 | 8.33 |
Gm48867 |
predicted gene, 48867 |
41275 |
0.14 |
chr12_98023692_98023910 | 8.33 |
Gm35412 |
predicted gene, 35412 |
76554 |
0.1 |
chr11_34314670_34314835 | 8.33 |
Insyn2b |
inhibitory synaptic factor family member 2B |
6 |
0.97 |
chr10_25571366_25571532 | 8.32 |
Gm29571 |
predicted gene 29571 |
35063 |
0.13 |
chr11_89623771_89624107 | 8.32 |
Ankfn1 |
ankyrin-repeat and fibronectin type III domain containing 1 |
72906 |
0.13 |
chr14_108910807_108911318 | 8.31 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
3096 |
0.41 |
chr16_72959177_72959642 | 8.30 |
Robo1 |
roundabout guidance receptor 1 |
16940 |
0.29 |
chr14_47911761_47912146 | 8.29 |
4930447J18Rik |
RIKEN cDNA 4930447J18 gene |
13044 |
0.17 |
chr11_67860869_67861044 | 8.26 |
Usp43 |
ubiquitin specific peptidase 43 |
15663 |
0.17 |
chr3_16938729_16939072 | 8.22 |
Gm26485 |
predicted gene, 26485 |
115588 |
0.07 |
chr15_18818116_18818289 | 8.22 |
C030047K22Rik |
RIKEN cDNA C030047K22 gene |
572 |
0.56 |
chr8_76252506_76252738 | 8.21 |
Gm22509 |
predicted gene, 22509 |
21828 |
0.19 |
chr12_39027318_39027481 | 8.20 |
Gm19563 |
predicted gene, 19563 |
28745 |
0.18 |
chr13_83880301_83880686 | 8.19 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
10715 |
0.21 |
chr12_47164470_47164875 | 8.18 |
Gm36971 |
predicted gene, 36971 |
370 |
0.91 |
chr16_43603831_43604250 | 8.16 |
Mir568 |
microRNA 568 |
36615 |
0.15 |
chr6_55680988_55681310 | 8.15 |
Neurod6 |
neurogenic differentiation 6 |
114 |
0.97 |
chr9_35402474_35402797 | 8.15 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
18493 |
0.14 |
chr13_18856177_18856400 | 8.12 |
Vps41 |
VPS41 HOPS complex subunit |
11425 |
0.23 |
chr17_88675649_88675800 | 8.12 |
Gtf2a1l |
general transcription factor IIA, 1-like |
7028 |
0.19 |
chr1_98047731_98048151 | 8.11 |
B230216N24Rik |
RIKEN cDNA B230216N24 gene |
148 |
0.94 |
chr9_91456581_91456763 | 8.11 |
Gm29478 |
predicted gene 29478 |
52198 |
0.11 |
chr6_6869733_6869901 | 8.10 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
1775 |
0.24 |
chr6_12488973_12489183 | 8.10 |
Thsd7a |
thrombospondin, type I, domain containing 7A |
66035 |
0.12 |
chr13_72298631_72298782 | 8.08 |
Gm4052 |
predicted gene 4052 |
51515 |
0.15 |
chr13_84449354_84449551 | 8.08 |
Gm26927 |
predicted gene, 26927 |
109339 |
0.06 |
chr5_77838512_77838806 | 8.06 |
Gm42673 |
predicted gene 42673 |
70801 |
0.12 |
chr18_89564398_89564718 | 8.06 |
Dok6 |
docking protein 6 |
4489 |
0.24 |
chr3_137529694_137529872 | 7.99 |
Gm4861 |
predicted gene 4861 |
22839 |
0.2 |
chr17_60234568_60234719 | 7.97 |
Gm29051 |
predicted gene 29051 |
103768 |
0.08 |
chr17_13654565_13655321 | 7.96 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr2_34107198_34107369 | 7.96 |
C230014O12Rik |
RIKEN cDNA C230014O12 gene |
446 |
0.84 |
chr16_72222039_72222224 | 7.95 |
8030451O07Rik |
RIKEN cDNA 8030451O07 gene |
12171 |
0.29 |
chr2_105674521_105675719 | 7.93 |
Pax6 |
paired box 6 |
11 |
0.97 |
chr12_50111748_50111899 | 7.93 |
Gm40418 |
predicted gene, 40418 |
8486 |
0.33 |
chr1_139346382_139347077 | 7.90 |
Crb1 |
crumbs family member 1, photoreceptor morphogenesis associated |
18461 |
0.17 |
chr4_43407185_43407401 | 7.88 |
Rusc2 |
RUN and SH3 domain containing 2 |
36 |
0.96 |
chr2_123533001_123533494 | 7.86 |
Gm13988 |
predicted gene 13988 |
259323 |
0.02 |
chr8_83187429_83187678 | 7.86 |
Gm10645 |
predicted gene 10645 |
21383 |
0.16 |
chr2_138405865_138406048 | 7.80 |
Btbd3 |
BTB (POZ) domain containing 3 |
127463 |
0.06 |
chr5_57475064_57475312 | 7.80 |
Gm6615 |
predicted gene 6615 |
15028 |
0.2 |
chr14_24526163_24526329 | 7.80 |
Rps24 |
ribosomal protein S24 |
35097 |
0.13 |
chr4_75213011_75213603 | 7.79 |
Dmac1 |
distal membrane arm assembly complex 1 |
64998 |
0.1 |
chr3_31903636_31903866 | 7.77 |
Kcnmb2 |
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
1048 |
0.65 |
chr6_141568214_141568517 | 7.77 |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
22201 |
0.23 |
chr9_61468991_61469397 | 7.77 |
Gm47240 |
predicted gene, 47240 |
3792 |
0.23 |
chr17_90088070_90088242 | 7.76 |
Nrxn1 |
neurexin I |
16 |
0.99 |
chr9_44456821_44456985 | 7.75 |
Upk2 |
uroplakin 2 |
1927 |
0.12 |
chr8_32959326_32959711 | 7.75 |
Gm3985 |
predicted gene 3985 |
9492 |
0.28 |
chr16_16561093_16561486 | 7.75 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
1070 |
0.53 |
chr7_74324897_74325154 | 7.74 |
Slco3a1 |
solute carrier organic anion transporter family, member 3a1 |
22206 |
0.23 |
chr7_132158684_132158869 | 7.73 |
Cpxm2 |
carboxypeptidase X 2 (M14 family) |
4037 |
0.23 |
chr1_172057571_172057962 | 7.72 |
Nhlh1 |
nescient helix loop helix 1 |
193 |
0.9 |
chr4_59629230_59629412 | 7.72 |
E130308A19Rik |
RIKEN cDNA E130308A19 gene |
3078 |
0.26 |
chr6_55388308_55389212 | 7.71 |
6430584L05Rik |
RIKEN cDNA 6430584L05 gene |
8127 |
0.17 |
chr18_12025849_12026003 | 7.71 |
Tmem241 |
transmembrane protein 241 |
48705 |
0.14 |
chr3_29541386_29541537 | 7.70 |
Egfem1 |
EGF-like and EMI domain containing 1 |
27555 |
0.23 |
chr3_70482886_70483059 | 7.69 |
Gm6631 |
predicted gene 6631 |
69653 |
0.12 |
chr17_73507966_73508157 | 7.68 |
AC107792.1 |
Novel transcript |
9694 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.7 | 38.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.9 | 34.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
4.8 | 14.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
4.6 | 13.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
4.5 | 13.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
4.0 | 12.0 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
3.5 | 17.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
3.1 | 12.5 | GO:0007412 | axon target recognition(GO:0007412) |
3.0 | 9.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.9 | 11.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.8 | 22.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.7 | 16.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
2.4 | 38.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
2.4 | 2.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
2.4 | 16.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.2 | 4.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.2 | 23.9 | GO:0071625 | vocalization behavior(GO:0071625) |
2.2 | 6.5 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.1 | 6.4 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
2.0 | 6.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
2.0 | 6.0 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.9 | 7.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.9 | 20.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.8 | 7.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.8 | 14.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.8 | 5.3 | GO:0001757 | somite specification(GO:0001757) |
1.7 | 5.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.7 | 6.9 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.6 | 6.5 | GO:0061743 | motor learning(GO:0061743) |
1.6 | 4.8 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.6 | 4.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.5 | 4.5 | GO:0021828 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.5 | 4.5 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.5 | 13.6 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.5 | 3.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.5 | 4.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.5 | 1.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.4 | 2.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.4 | 7.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
1.4 | 8.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.4 | 5.5 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.4 | 4.1 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.3 | 9.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.3 | 4.0 | GO:0030070 | insulin processing(GO:0030070) |
1.3 | 5.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.3 | 5.2 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.3 | 7.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.3 | 6.5 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.3 | 5.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.3 | 2.6 | GO:0021564 | vagus nerve development(GO:0021564) |
1.3 | 3.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.2 | 2.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.2 | 6.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.2 | 5.0 | GO:0001927 | exocyst assembly(GO:0001927) |
1.2 | 6.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.2 | 6.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.2 | 24.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.2 | 4.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.2 | 7.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.2 | 3.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.2 | 4.6 | GO:0030035 | microspike assembly(GO:0030035) |
1.2 | 3.5 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.1 | 4.6 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.1 | 2.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.1 | 19.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.1 | 3.4 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.1 | 11.2 | GO:0008038 | neuron recognition(GO:0008038) |
1.1 | 3.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.1 | 9.6 | GO:0050957 | equilibrioception(GO:0050957) |
1.1 | 3.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.0 | 1.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
1.0 | 3.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.0 | 13.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.0 | 3.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.0 | 12.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.0 | 7.9 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.0 | 3.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.0 | 4.9 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.0 | 3.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.0 | 2.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.0 | 11.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.0 | 1.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.0 | 11.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
1.0 | 1.9 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
1.0 | 1.9 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
1.0 | 8.6 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.9 | 2.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.9 | 0.9 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.9 | 8.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.9 | 3.7 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.9 | 5.5 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.9 | 2.7 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.9 | 2.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.9 | 9.8 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.9 | 3.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.9 | 3.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.9 | 1.7 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.8 | 2.5 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.8 | 2.5 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.8 | 2.5 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.8 | 3.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.8 | 1.7 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.8 | 0.8 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.8 | 2.5 | GO:0090427 | activation of meiosis(GO:0090427) |
0.8 | 13.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.8 | 4.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.8 | 1.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.8 | 2.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.8 | 7.9 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.8 | 10.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.8 | 7.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.8 | 5.4 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.8 | 0.8 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.8 | 3.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.8 | 8.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.8 | 2.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.8 | 1.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.8 | 9.8 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.7 | 6.7 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.7 | 5.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.7 | 4.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.7 | 7.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.7 | 54.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 2.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.7 | 1.4 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.7 | 3.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.7 | 0.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.7 | 5.4 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.7 | 2.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.7 | 2.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.7 | 2.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.7 | 9.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.7 | 1.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.7 | 1.3 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.7 | 1.3 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.6 | 1.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.6 | 1.2 | GO:0015705 | iodide transport(GO:0015705) |
0.6 | 1.2 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.6 | 3.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.6 | 1.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.6 | 3.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.6 | 3.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.6 | 0.6 | GO:0046959 | habituation(GO:0046959) |
0.6 | 25.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.6 | 3.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.6 | 0.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.6 | 1.7 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.6 | 1.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.6 | 2.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.6 | 1.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.6 | 1.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.5 | 4.9 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.5 | 1.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.5 | 1.6 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.5 | 1.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.5 | 1.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.5 | 1.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 2.7 | GO:0006971 | hypotonic response(GO:0006971) |
0.5 | 0.5 | GO:0098597 | observational learning(GO:0098597) |
0.5 | 2.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.5 | 1.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.5 | 1.0 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.5 | 1.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.5 | 1.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 2.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 4.0 | GO:0001964 | startle response(GO:0001964) |
0.5 | 1.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.5 | 14.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.5 | 3.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.5 | 4.0 | GO:0006983 | ER overload response(GO:0006983) |
0.5 | 1.5 | GO:2001023 | regulation of response to drug(GO:2001023) positive regulation of response to drug(GO:2001025) |
0.5 | 1.9 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.5 | 3.4 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.5 | 1.5 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.5 | 1.9 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.5 | 1.4 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.5 | 1.0 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 | 1.9 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.5 | 1.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.5 | 1.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.5 | 2.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.5 | 0.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.5 | 1.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.5 | 0.5 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.5 | 4.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.5 | 4.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.5 | 3.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.5 | 1.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 1.3 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.4 | 1.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.4 | 0.4 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.4 | 0.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.4 | 1.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 0.9 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.4 | 1.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.4 | 0.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.4 | 3.8 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 0.8 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 6.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.4 | 0.8 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.4 | 0.8 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.4 | 0.8 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.4 | 0.8 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.4 | 2.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 | 0.8 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.4 | 1.6 | GO:0060437 | lung growth(GO:0060437) |
0.4 | 1.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.4 | 1.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.4 | 2.0 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.4 | 0.4 | GO:0097369 | sodium ion import(GO:0097369) |
0.4 | 1.2 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.4 | 1.6 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.4 | 4.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 1.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 1.1 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.4 | 1.9 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.4 | 1.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 1.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 6.0 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.4 | 1.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 8.2 | GO:0007616 | long-term memory(GO:0007616) |
0.4 | 2.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.4 | 1.8 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.4 | 1.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 1.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 0.7 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.4 | 2.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.4 | 0.7 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.4 | 1.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.4 | 8.0 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.4 | 0.7 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.4 | 1.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 2.9 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.4 | 4.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 7.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.4 | 6.1 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.4 | 0.7 | GO:0021554 | optic nerve development(GO:0021554) |
0.3 | 2.4 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 3.8 | GO:0060074 | synapse maturation(GO:0060074) |
0.3 | 1.0 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 2.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.3 | 1.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 1.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 0.3 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.3 | 1.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.3 | 0.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.3 | 1.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 0.3 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.3 | 0.3 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 2.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.3 | 1.7 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 1.0 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.3 | 1.7 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.3 | 1.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 1.0 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 0.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 3.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.3 | 1.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 1.0 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.3 | 2.9 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.3 | 2.6 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.3 | 9.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 0.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 0.6 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.3 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.9 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.3 | 1.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 0.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 0.6 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.3 | 5.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 1.2 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.3 | 0.6 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.3 | 1.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 0.9 | GO:0008355 | olfactory learning(GO:0008355) |
0.3 | 2.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 0.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 2.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.3 | 1.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.3 | 0.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 0.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 0.3 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.3 | 0.6 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.3 | 1.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 0.9 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.3 | 0.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 2.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.3 | 1.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.3 | 2.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 1.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.3 | 1.7 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 0.8 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.3 | 0.8 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.3 | 3.6 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.3 | 2.5 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.3 | 0.8 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.3 | 1.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 0.5 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.3 | 0.8 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 2.1 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 1.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.3 | 0.3 | GO:0021756 | striatum development(GO:0021756) |
0.3 | 0.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 1.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.3 | 1.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 0.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 2.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 3.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.7 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 5.4 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 0.2 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 1.9 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.7 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 0.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 3.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.5 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.2 | 0.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.9 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.2 | 0.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.5 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.2 | 1.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 1.4 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 0.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.2 | 0.9 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 5.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 1.4 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.7 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.5 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.2 | 0.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 0.7 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.2 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.2 | 1.1 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
0.2 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 3.1 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.2 | 1.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.7 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.2 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.2 | 0.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 1.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 0.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 1.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 0.4 | GO:0003157 | endocardium development(GO:0003157) |
0.2 | 0.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 1.0 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 4.5 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.2 | 0.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.2 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.2 | 0.4 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.2 | 0.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 0.2 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.2 | 0.4 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.2 | 0.4 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 1.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.2 | 1.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.4 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.2 | 0.4 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 0.4 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.4 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 0.4 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.4 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.2 | 2.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 0.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.2 | 0.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.2 | 1.3 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 1.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.5 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 0.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.2 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.7 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 0.9 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.2 | 1.4 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 1.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.5 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 0.5 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 1.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 1.2 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.5 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 0.7 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 0.5 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 0.5 | GO:0072017 | distal tubule development(GO:0072017) |
0.2 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 1.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.6 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.2 | 0.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.9 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.3 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
0.1 | 0.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 0.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 1.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.7 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.7 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.5 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.5 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.8 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 1.6 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.7 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.1 | 0.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 1.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.4 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.2 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.5 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.5 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.1 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 0.6 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 0.8 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 1.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.5 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.3 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.5 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.8 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.5 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.1 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 0.2 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.4 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 2.0 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.3 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 1.3 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.2 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.3 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 1.0 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.3 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.4 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.2 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.3 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.2 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.2 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.2 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.3 | GO:0036376 | sodium ion export from cell(GO:0036376) sodium ion export(GO:0071436) |
0.1 | 0.3 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.1 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.3 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.1 | 0.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.1 | 0.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.2 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 0.1 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.1 | 0.1 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.1 | 0.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.3 | GO:0048265 | response to pain(GO:0048265) |
0.1 | 0.6 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.6 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.3 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.2 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.1 | 0.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 1.0 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.6 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.0 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.5 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 1.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.2 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.1 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.0 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.9 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.0 | 1.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.1 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.0 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.1 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.0 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.0 | 0.0 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.0 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.0 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.0 | 0.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.0 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 15.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.8 | 16.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.7 | 13.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.1 | 12.4 | GO:0071986 | Ragulator complex(GO:0071986) |
2.1 | 10.3 | GO:0071547 | piP-body(GO:0071547) |
2.0 | 5.9 | GO:0044308 | axonal spine(GO:0044308) |
2.0 | 5.9 | GO:0072534 | perineuronal net(GO:0072534) |
1.9 | 5.6 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.9 | 18.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.8 | 7.4 | GO:0033010 | paranodal junction(GO:0033010) |
1.7 | 30.3 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.6 | 19.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.6 | 41.8 | GO:0044295 | axonal growth cone(GO:0044295) |
1.6 | 6.4 | GO:0033269 | internode region of axon(GO:0033269) |
1.4 | 8.6 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.3 | 1.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.3 | 12.7 | GO:0030673 | axolemma(GO:0030673) |
1.2 | 11.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.2 | 19.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.2 | 10.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.1 | 53.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.1 | 3.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.1 | 3.4 | GO:0045298 | tubulin complex(GO:0045298) |
1.1 | 2.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.9 | 3.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.9 | 2.6 | GO:0036396 | MIS complex(GO:0036396) |
0.8 | 4.1 | GO:0097433 | dense body(GO:0097433) |
0.8 | 2.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.8 | 5.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.8 | 5.3 | GO:0071437 | invadopodium(GO:0071437) |
0.8 | 11.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.7 | 1.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 2.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.7 | 1.5 | GO:0097441 | basilar dendrite(GO:0097441) |
0.7 | 2.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.7 | 2.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.7 | 6.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.7 | 4.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.7 | 18.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 4.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.7 | 7.2 | GO:0042555 | MCM complex(GO:0042555) |
0.6 | 6.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.6 | 1.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.6 | 0.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.6 | 3.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.6 | 4.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.6 | 4.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.6 | 5.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.6 | 1.7 | GO:0032280 | symmetric synapse(GO:0032280) |
0.6 | 1.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.5 | 2.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.5 | 2.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.5 | 7.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.5 | 5.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.5 | 13.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.5 | 1.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 24.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 2.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.4 | 1.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 4.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 1.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.4 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 1.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 9.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 1.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.4 | 1.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 2.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 1.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 4.7 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 0.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 1.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 0.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.3 | 2.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 1.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 45.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 1.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 1.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 2.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 0.9 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 4.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.3 | 1.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 0.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 2.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 1.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 0.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 3.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 1.7 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 2.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 1.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 2.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 0.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.3 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.2 | 0.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.2 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.7 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 3.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 1.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 3.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 2.5 | GO:0043205 | fibril(GO:0043205) |
0.2 | 1.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 15.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 1.7 | GO:0030430 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.2 | 1.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 3.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 11.2 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 18.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 8.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 2.3 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 1.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.9 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 1.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 1.6 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.4 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.5 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 2.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 1.1 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.0 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.0 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 30.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
6.4 | 19.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
5.3 | 21.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.8 | 15.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.6 | 7.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.4 | 2.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
2.4 | 12.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.3 | 11.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
2.2 | 6.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
2.1 | 10.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.9 | 13.3 | GO:0003680 | AT DNA binding(GO:0003680) |
1.9 | 5.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.8 | 7.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.7 | 5.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.7 | 8.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.7 | 6.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.7 | 6.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.7 | 6.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.6 | 11.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.6 | 12.9 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.5 | 6.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.4 | 5.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.4 | 8.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.4 | 12.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.3 | 5.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.3 | 26.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.3 | 2.6 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.3 | 2.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.3 | 5.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
1.2 | 7.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.2 | 4.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.2 | 2.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.1 | 4.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.0 | 3.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.0 | 5.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.0 | 3.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.0 | 2.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.0 | 15.2 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.9 | 2.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.9 | 2.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.9 | 4.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.9 | 4.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.9 | 0.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.9 | 2.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.9 | 5.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.9 | 2.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.8 | 3.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.8 | 4.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.8 | 1.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.8 | 3.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.8 | 2.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.8 | 5.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.8 | 3.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.8 | 11.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.7 | 2.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.7 | 6.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.7 | 0.7 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.7 | 8.5 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.7 | 2.8 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.7 | 6.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.7 | 12.4 | GO:0005112 | Notch binding(GO:0005112) |
0.7 | 6.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.7 | 3.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.7 | 7.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.7 | 7.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.7 | 3.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.7 | 2.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.6 | 2.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.6 | 3.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 1.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.6 | 1.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.6 | 3.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.6 | 2.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.6 | 10.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.6 | 2.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.6 | 2.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 3.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 1.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.6 | 8.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.6 | 2.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.6 | 1.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.6 | 1.7 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.6 | 7.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 17.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 4.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.5 | 2.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.5 | 2.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 1.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 13.0 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.5 | 1.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 1.5 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.5 | 1.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.5 | 1.5 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.5 | 1.9 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.5 | 0.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.5 | 7.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 1.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.5 | 0.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 10.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.5 | 1.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 1.8 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 3.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.4 | 4.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.4 | 1.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.4 | 1.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 1.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 3.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 2.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 3.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.4 | 5.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 2.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.4 | 2.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.4 | 2.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 11.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 3.8 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.4 | 7.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.4 | 2.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.4 | 11.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 1.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 1.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 1.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.4 | 1.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 1.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 1.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.4 | 2.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.4 | 3.5 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.3 | 5.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 1.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 1.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 1.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 0.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 2.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 4.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 0.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 1.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 1.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 10.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 1.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 2.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.3 | 1.6 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 13.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 3.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 1.8 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.3 | 0.3 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.3 | 0.9 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 1.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 0.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 0.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 4.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 0.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 2.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 1.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 0.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 1.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 1.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 1.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 3.1 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 2.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 1.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 2.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 5.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 1.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 1.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 3.4 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 0.4 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 0.7 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 0.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 1.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 2.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 1.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 1.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 2.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 3.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 0.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 4.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 0.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.8 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 7.1 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 0.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 2.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 0.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 3.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 3.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.6 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.7 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 1.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 1.5 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 2.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 1.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 1.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.5 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 3.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 2.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 1.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.2 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 1.2 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.9 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 2.6 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.0 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.0 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.0 | 1.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 5.3 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 5.9 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 12.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.7 | 13.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 0.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 1.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.5 | 13.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 7.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 12.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.4 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.4 | 0.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 10.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 5.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 7.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 2.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 8.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 2.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 3.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 24.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
2.1 | 22.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.5 | 22.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.4 | 20.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.2 | 2.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.1 | 1.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.1 | 27.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.0 | 16.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.0 | 17.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.9 | 9.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.8 | 11.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.8 | 1.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.6 | 5.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.6 | 12.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.6 | 5.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.6 | 22.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 1.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.5 | 15.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 3.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 8.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 0.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 9.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 4.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 2.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 3.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 5.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 2.8 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 3.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 0.6 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.3 | 2.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 7.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 1.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 0.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.3 | 1.8 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.2 | 2.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 4.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 0.7 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 3.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.7 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.2 | 1.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 3.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 4.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 0.2 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 2.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 0.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 1.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 1.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.3 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 1.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 0.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 1.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 2.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 1.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.9 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.0 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.0 | 0.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |